You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sutent

Showing 1 - 25 of 292
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

Active, not recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
  • +1 more
Oct 11, 2022

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)

Active, not recruiting
Has Results
  • Thymoma
  • Thymus Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022

Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
    University of Miami
Jan 3, 2023

Bioequivalence Trial in Lesnoy (Aviga, capsules 50 mg / Sutent®, capsules 50 mg, Sutent®, capsules 50 mg / Aviga, capsules 50

Not yet recruiting
  • Bioequivalence
  • Aviga, capsules 50 mg / Sutent®, capsules 50 mg
  • Sutent®, capsules 50 mg / Aviga, capsules 50 mg
  • Lesnoy, Minsk Region, Belarus
    National Anti-Doping Laboratory
Jan 20, 2022

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
Has Results
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Jan 9, 2023

GIST Trial (Ripretinib, Sunitinib)

Not yet recruiting
  • GIST
  • (no location specified)
Feb 8, 2023

Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

Recruiting
  • Non-Clear Cell Renal Cell Carcinoma
  • Duarte, California
    Exelixis Clinical Site #1
Jan 13, 2023

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Lebanon, New Hampshire
  • +1 more
Aug 9, 2022

Renal Cell Carcinoma (RCC) Trial in Heidelberg (Chimeric mAb cG250, Sunitinib malate)

Terminated
Has Results
  • Renal Cell Carcinoma (RCC)
  • Chimeric monoclonal antibody cG250
  • Sunitinib malate
  • Heidelberg, Victoria, Australia
    Austin Health (Ludwig Institute Oncology Unit)
Oct 3, 2022

Gliosarcoma, CNS Sarcoma Trial run by the NCI (Sunitinib, wGT3x-BT)

Terminated
Has Results
  • Gliosarcoma
  • Central Nervous System Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 24, 2022

Patterns With Targeted Therapies In Mrcc In Sweden - A

Completed
  • Kidney Neoplasms
  • Sollentuna, Sweden
    Pfizer Innovations AB
Sep 8, 2021

Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 17, 2022

Thymic Carcinoma Trial in Columbus (other, biological, drug)

Recruiting
  • Thymic Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

Real-world Clinical Patterns Of Care And Outcomes Among AfME

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Algers, Algeria
  • +5 more
Aug 16, 2022

Renal Cell Carcinoma Metastatic Trial in Hershey (Abemaciclib, Sunitinib)

Active, not recruiting
  • Renal Cell Carcinoma Metastatic
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Jan 5, 2022

Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab

Recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
  • +7 more
  • Bologna, Italy
  • +12 more
Nov 10, 2021

Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

Withdrawn
  • Clear-cell Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
    University of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022

Carcinoma, Renal Cell Trial in Durham (Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Durham, North Carolina
    Duke Cancer Institute
Nov 23, 2020

Papillary Thyroid Cancer, Follicular Thyroid Cancer, Differentiated Thyroid Cancer Trial in Washington (SU011248, Sutent)

Completed
Has Results
  • Papillary Thyroid Cancer
  • +2 more
  • SU011248, Sutent
  • Washington, District of Columbia
    MedStar Washington Hospital Center
Aug 3, 2020

Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)

Active, not recruiting
  • Paraganglioma
  • Pheochromocytoma
  • Calgary, Alberta, Canada
  • +3 more
Nov 29, 2021

Cancer Trial in Canada, United States (BBI503, Capecitabine, Doxorubicin)

Completed
  • Cancer
  • Fort Wayne, Indiana
  • +7 more
Apr 4, 2022

Metastatic Breast Cancer Trial in Houston (Exemestane, Sutent)

Terminated
Has Results
  • Metastatic Breast Cancer
  • Houston, Texas
    Baylor College of Medicine, Lester and Sue Smith Breast Center
Jul 9, 2020

Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)

Terminated
Has Results
  • Kidney Cancer
  • Boston, Massachusetts
  • +3 more
Apr 26, 2021